{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T16:15:10Z","timestamp":1773850510251,"version":"3.50.1"},"reference-count":62,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T00:00:00Z","timestamp":1658707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Recent studies have reported that pulmo-neurotropic viruses can cause systemic invasion leading to acute respiratory failure and neuroinfection. The tetracycline class of secondary metabolites of microorganisms is effective against several migrating neurotropic viral disorders, as Japanese-Encephalitis (JE), Severe-Acute-Respiratory-Syndrome Coronavirus-2 (SARS-COV2), Human-Immunodeficiency-Virus (HIV), and Simian-Immunodeficiency-Virus (SIV). Another microbial secondary metabolite, cephalosporin, can be used for anti-viral combination therapy. However, a substantial public health debacle is viral resistance to such antibiotics, and, thus, one needs to explore the antiviral efficiency of other secondary metabolites, as phytochemicals. Hence, here, we investigate phytochemicals like podophyllotoxin, chlorogenic acid, naringenin, and quercetin for therapeutic efficiency in neurotropic viral infections.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>To investigate the possibility of the afferent neural pathway of migrating virus in man, MRI scanning was performed on human subjects, whereby the connections between cranial nerves and the brain-stem\/limbic-region were assessed by fiber-tractography. Moreover, human clinical-trial assessment (<jats:italic>n<\/jats:italic> = 140, <jats:italic>p<\/jats:italic> = 0.028) was done for formulating a quantitative model of antiviral pharmacological intervention. Furthermore, docking studies were performed to identify the binding affinity of phytochemicals toward antiviral targets as (i) host receptor [Angiotensin-converting Enzyme-2], (ii) main protease of SARS-COV2 virus (iii) NS3-Helicase\/Nucleoside triphosphatase of Japanese-encephalitis-virus, and the affinities were compared to standard tetracycline and cephalosporin antibiotics. Then, network pharmacology analysis was utilized to identify the possible mechanism of action of those phytochemicals.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Human MRI-tractography analysis showed fiber connectivity, as: (a) Path-1: From the olfactory nerve to the limbic region (2) Path-2: From the peripheral glossopharyngeal nerve and vagus nerves to the midbrain-respiratory-center. Docking studies revealed comparable binding affinity of phytochemicals, tetracycline, and cephalosporin antibiotics toward both (a) virus receptors, (b) host cell receptors where virus-receptor binds. The phytochemicals effectively countered the cytokine storm-induced neuroinflammation, a critical pathogenic pathway. We also found that a systems-biology-based double-hit mathematical bi-exponential model accounts for patient survival-curve under antiviral treatment, thus furnishing a quantitative-clinical framework of secondary metabolite action on virus and host cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Due to the current viral resistance to antibiotics, we identified novel phytochemicals that can have clinical therapeutic application to neurotropic virus infection. Based on human MRI scanning and clinical-trial analysis, we demarcated the anatomical pathway and systems-biology-based quantitative formulation of the mechanism of antiviral action.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnins.2022.917867","type":"journal-article","created":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T09:36:43Z","timestamp":1658741803000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Neuroprotective Drug Discovery From Phytochemicals and Metabolites for CNS Viral Infection: A Systems Biology Approach With Clinical and Imaging Validation"],"prefix":"10.3389","volume":"16","author":[{"given":"Anindita","family":"Bhattacharjee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pratik","family":"Purohit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prasun K.","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3389\/fneur.2016.00094","article-title":"Systems biology of immunomodulation for post-stroke neuroplasticity: multimodal implications of pharmacotherapy and neurorehabilitation","volume":"7","author":"Alam","year":"2016","journal-title":"Front. Neurol."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.570919","article-title":"Perspective: The Potential effects of naringenin in COVID19","author":"Alberca","year":"2020","journal-title":"Front. Immunol."},{"key":"B3","first-page":"1061","article-title":"Pharmacotherapeutics of the newer tetracyclines","volume":"176","author":"Aronson","year":"1980","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.2147\/IDR.S173867","article-title":"Antibiotic resistance: a rundown of a global crisis","volume":"11","author":"Aslam","year":"2018","journal-title":"Infect. Drug Resist."},{"key":"B5","doi-asserted-by":"publisher","first-page":"D36","DOI":"10.1093\/nar\/gku1055","article-title":"Gene: a gene-centered information resource at NCBI","volume":"43","author":"Brown","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1016\/j.neuroscience.2008.04.036","article-title":"Minocycline provides protection against \u03b2-amyloid (25-35)-induced alterations of the somatostatin signaling pathway in the rat temporal cortex","volume":"154","author":"Burgos-Ramos","year":"2008","journal-title":"Neuroscience"},{"key":"B7","first-page":"2781","article-title":"Editorial\u2013differences and similarities between severe acute respiratory syndrome (SARS)-CoronaVirus (CoV) and SARS-COV2. Would a rose by another name smell as sweet?","volume":"24","author":"Ceccarelli","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1002\/ptr.6887","article-title":"A role for quercetin in coronavirus disease 2019 (COVID-19)","volume":"35","author":"Derosa","year":"2021","journal-title":"Phytotherapy Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep45723","article-title":"Antiviral activity of chlorogenic acid against influenza A (H1N1\/H3N2) virus and its inhibition of neuraminidase","volume":"7","author":"Ding","year":"2017","journal-title":"Sci. Rep."},{"key":"B10","article-title":"Use of minocycline in viral infections","author":"Dutta","year":"2011","journal-title":"Indian J. Med. Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1097\/NEN.0b013e3182588293","article-title":"Neuroanatomic connectivity of the human ascending arousal system critical to consciousness and its disorders","volume":"71","author":"Edlow","year":"2012","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3233\/JAD-200581","article-title":"Neurobiology of COVID19","volume":"76","author":"Fotuhi","year":"2020","journal-title":"J. Alzheimer's Dis."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.11.3_Pt_2.II37","article-title":"Angiotensin converting enzyme inhibitors. Properties and side effects","author":"Gavras","year":"1988","journal-title":"Hypertension"},{"key":"B14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1189\/jlb.0804477","article-title":"Minocycline attenuates T cell and microglia activity to impair cytokine production in T cell-microglia interaction","volume":"78","author":"Giuliani","year":"2005","journal-title":"J. Leukoc. Biol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/(SICI)1099-1352(199601)9:1&lt;1::AID-JMR241&gt;3.0.CO;2-6","article-title":"Automated docking of flexible ligands: applications of AutoDock","volume":"9","author":"Goodsell","year":"1996","journal-title":"J. Molecular Recognit."},{"key":"B16","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/hep.20069","article-title":"Severe acute respiratory syndrome and the liver","volume":"39","author":"Humar","year":"2004","journal-title":"Hepatology."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.freeradbiomed.2011.06.017","article-title":"Accumulation of orally administered quercetin in brain tissue and its antioxidative effects in rats","volume":"51","author":"Ishisaka","year":"2011","journal-title":"Free Radical Biol. Med."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of M pro from SARS-COV2 and discovery of its inhibitors","author":"Jin","year":"2020","journal-title":"Nature."},{"key":"B19","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1080\/00498254.2018.1445882","article-title":"Pharmacokinetics and brain penetration study of chlorogenic acid in rats","volume":"49","author":"Kumar","year":"2019","journal-title":"Xenobiotica."},{"key":"B20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12879-016-1385-6","article-title":"Role of oral minocycline in acute encephalitis syndrome in India\u2013a randomized controlled trial","volume":"16","author":"Kumar","year":"","journal-title":"BMC Infect. Dis."},{"key":"B21","first-page":"1","article-title":"Role of oral minocycline in acute encephalitis syndrome in India\u2013a randomized controlled trial","volume":"16","author":"Kumar","year":"","journal-title":"BMC Infect. Dis."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-COV2 spike receptor-binding domain bound to the ACE2 receptor","author":"Lan","year":"2020","journal-title":"Nature."},{"key":"B23","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.compbiomed.2018.05.012","article-title":"Across the blood-brain barrier: Neurotherapeutic screening and characterization of naringenin as a novel CRMP-2 inhibitor in the treatment of Alzheimer's disease using bioinformatics and computational tools","volume":"98","author":"Lawal","year":"2018","journal-title":"Comput. Biol. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/jmv.25728","article-title":"The neuroinvasive potential of SARS-CoV2 may be at least partially responsible for the respiratory failure of COVID-19 patients","volume":"92","author":"Li","year":"2020","journal-title":"J Med Virol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"102474","DOI":"10.1016\/j.amjoto.2020.102474","article-title":"Upper airway symptoms in coronavirus disease 2019 (COVID19)","volume":"41","author":"Lovato","year":"2020","journal-title":"Am J Otolaryngol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1007\/s00044-010-9336-z","article-title":"Docking study on chlorogenic acid as a potential H5N1 influenza A virus neuraminidase inhibitor","volume":"20","author":"Luo","year":"2011","journal-title":"Medicinal Chemi. Res."},{"key":"B27","first-page":"1152","article-title":"Quantitative estimation of phytochemicals and antimicrobial activity of Podophyllum hexandrum","volume":"6","author":"Malik","year":"2018","journal-title":"Int. J. Curr. Sci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1128\/JVI.02012-06","article-title":"Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus","volume":"81","author":"McCray","year":"2007","journal-title":"J. Virol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41593-020-00758-5","article-title":"Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19","volume":"24","author":"Meinhardt","year":"2021","journal-title":"Nat. Neurosci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.diagmicrobio.2014.12.011","article-title":"Update of the telavancin activity in vitro tested against a worldwide collection of Gram-positive clinical isolates (2013), when applying the revised susceptibility testing method","volume":"81","author":"Mendes","year":"2015","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"D183","DOI":"10.1093\/nar\/gkw1138","article-title":"PANTHER version 11: expanded annotation data from Gene Ontology and Reactome pathways, and data analysis tool enhancements","volume":"45","author":"Mi","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1093\/jac\/dkm307","article-title":"Minocycline inhibits West Nile virus replication and apoptosis in human neuronal cells","volume":"60","author":"Michaelis","year":"2007","journal-title":"J. Antimicrobial Chemother."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1111\/j.1471-4159.2008.05238.x","article-title":"Minocycline neuroprotects, reduces microglial activation, inhibits caspase 3 induction, and viral replication following Japanese encephalitis","volume":"105","author":"Mishra","year":"2008","journal-title":"J. Neurochem."},{"key":"B34","doi-asserted-by":"publisher","first-page":"4695","DOI":"10.13040\/IJPSR.0975-8232.6(11).4695-04","article-title":"Therapeutic potential of bioactive phytochemicals by inhibiting \u03b2-lactamase of multidrug resistant clinical isolates","volume":"6","author":"Moon","year":"2015","journal-title":"IJPSR."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cytogfr.2021.02.002","article-title":"SARS-COV2 mediated neuroinflammation and the impact of COVID19 in neurological disorders","volume":"58","author":"Narayanappa","year":"2021","journal-title":"Cytokine Growth Factor Rev."},{"key":"B36","doi-asserted-by":"publisher","first-page":"184","DOI":"10.15406\/mojpb.2018.07.00231","article-title":"A computational approach of antibiotics as novel drug target for Japanese encephalitis virus NS helicase\/nucleoside triphosphatase","volume":"7","author":"Nath","year":"2018","journal-title":"MOJ Proteomics Bioinf."},{"key":"B37","doi-asserted-by":"publisher","first-page":"7264","DOI":"10.1128\/JVI.00737-08","article-title":"Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2","volume":"82","author":"Netland","year":"2008","journal-title":"J. Virol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1128\/AAC.37.7.1393","article-title":"Penetration of lipophilic agents with multiple protonation sites into bacterial cells: tetracyclines and fluoroquinolones as examples","volume":"37","author":"Nikaido","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"B39","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.1093\/brain\/awaa240","article-title":"The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings","volume":"143","author":"Paterson","year":"2020","journal-title":"Brain"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e01564","DOI":"10.1128\/JVI.01564-16","article-title":"Neurovirulent murine coronavirus JHM. SD uses cellular zinc metalloproteases for virus entry and cell-cell fusion","volume":"91","author":"Phillips","year":"2017","journal-title":"J. Virol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/ana.10092","article-title":"Inhibition of autoimmune encephalomyelitis by a tetracycline","volume":"51","author":"Popovic","year":"2002","journal-title":"Annals Neurol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.2147\/DDDT.S164966","article-title":"In vitro and in vivo evaluation of cephalosporins for the treatment of Lyme disease","volume":"12","author":"Pothineni","year":"2018","journal-title":"Drug Des. Devel. Ther."},{"key":"B43","doi-asserted-by":"publisher","first-page":"966","DOI":"10.3390\/jcm10050966","article-title":"Smell and taste loss recovery time in COVID-19 patients and disease severity","volume":"10","author":"Printza","year":"2021","journal-title":"J. Clin. Med."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1093\/database\/baq020","article-title":"GeneCards Version 3: the human gene integrator","author":"Safran","year":"2010","journal-title":"Database."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.3389\/fimmu.2020.01949","article-title":"Overview of immune response during SARS-COV2 infection: lessons from the past","volume":"11","author":"Shah","year":"2020","journal-title":"Front. Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3390\/biom11040603","article-title":"Podophyllotoxin: History, Recent Advances and Future Prospects","volume":"11","author":"Shah","year":"2021","journal-title":"Biomolecules."},{"key":"B47","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/bioinformatics\/btq675","article-title":"Cytoscape 2.8: new features for data integration and network visualization","volume":"27","author":"Smoot","year":"2011","journal-title":"Bioinformatics."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1097\/00001756-200410050-00007","article-title":"Minocycline protects PC12 cells from ischemic-like injury and inhibits 5-lipoxygenase activation","volume":"15","author":"Song","year":"2004","journal-title":"Neuroreport."},{"key":"B49","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1093\/cid\/ciaa074","article-title":"Association between the use of antibiotics, antivirals, and hospitalizations among patients with laboratory-confirmed influenza","volume":"72","author":"Sutton","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"B50","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.biosystems.2014.11.005","article-title":"CytoNCA: a cytoscape plugin for centrality analysis and evaluation of protein interaction networks","volume":"127","author":"Tang","year":"2015","journal-title":"BioSystems."},{"key":"B51","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4939-3743-1_2","article-title":"\u201cThe gene ontology and the meaning of biological function,\u201d","volume-title":"The Gene Ontology Handbook","author":"Thomas","year":"2017"},{"key":"B52","doi-asserted-by":"publisher","first-page":"17996","DOI":"10.1074\/jbc.M311191200","article-title":"ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis","volume":"279","author":"Towler","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","article-title":"Renin\u2013angiotensin\u2013aldosterone system inhibitors in patients with COVID19","volume":"382","author":"Vaduganathan","year":"2020","journal-title":"N Engl J Med"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1080\/14786419.2021.1904923","article-title":"Chlorogenic acid, a natural product as potential inhibitor of COVID19: virtual screening experiment based on network pharmacology and molecular docking","author":"Wang","year":"2021","journal-title":"Nat. Prod. Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41368-020-0074-x","article-title":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa","volume":"12","author":"Xu","year":"2020","journal-title":"Int. J. Oral Sci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1126\/science.abb2762","article-title":"Structural basis for the recognition of SARS-COV2 by full-length human ACE2","volume":"367","author":"Yan","year":"2020","journal-title":"Science."},{"key":"B57","doi-asserted-by":"publisher","first-page":"e80713","DOI":"10.1371\/journal.pone.0080713","article-title":"Deterministic diffusion fiber tracking improved by quantitative anisotropy","volume":"8","author":"Yeh","year":"2013","journal-title":"PLoS ONE"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1109\/TMI.2010.2045126","article-title":"Generalized sampling imaging","volume":"29","author":"Yeh","year":"2010","journal-title":"IEEE Trans. Med. Imaging"},{"key":"B59","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/mrm.26143","article-title":"Mapping immune cell infiltration using restricted diffusion MRI","volume":"77","author":"Yeh","year":"2017","journal-title":"Magnetic resonance in medicine"},{"key":"B60","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1139\/O08-002","article-title":"Chemical biology of tetracycline antibiotics","volume":"86","author":"Zakeri","year":"2008","journal-title":"Biochemistry and Cell Biology"},{"key":"B61","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.coviro.2015.08.013","article-title":"Recent advances on viral manipulation of NF-\u03baB signaling pathway","volume":"15","author":"Zhao","year":"2015","journal-title":"Curr. Opin. Virol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1001\/jama.293.16.2003","article-title":"Neuroprotective and anti\u2013human immunodeficiency virus activity of minocycline","volume":"293","author":"Zink","year":"2005","journal-title":"JAMA"}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2022.917867\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T09:36:51Z","timestamp":1658741811000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2022.917867\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,25]]},"references-count":62,"alternative-id":["10.3389\/fnins.2022.917867"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2022.917867","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,25]]},"article-number":"917867"}}